Protein secreted by immune cells may help drive brain aging

· Medical Xpress

by Weill Cornell Medical College

edited by Lisa Lock, reviewed by Robert Egan

Lisa Lock

Scientific Editor

Meet our editorial team
Behind our editorial process

Robert Egan

Senior Editor

Meet our editorial team
Behind our editorial process Editors' notes

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

The GIST Add as preferred source


Microglia, shown in green, are part of the immune response that protect the brain. Credit: National Institute of Allergy and Infectious Diseases/NIH

Brain-resident immune cells that have reached an old-age state called "senescence" secrete a protein that causes dysfunction in other brain cells, according to a study led by investigators at Weill Cornell Medicine. The discovery sheds light on how aging impairs memory and cognition and makes the brain vulnerable to neurodegenerative disorders.

The researchers, whose findings are published in Neuron, observed that in a mouse model of accelerated aging, many immune cells in the brain enter a nondividing, dysfunctional, senescent state and begin secreting a protein called DLK1. This protein disrupts other brain cells, in particular neurons and the oligodendrocytes that help protect nerve fibers. The findings suggest that DLK1-driven dysfunction may be a key mechanism through which aging leads to reduced brain function and increased neurodegenerative disease risk.

"One strategy we hope to test is to neutralize this secreted protein in the brain to see if that effectively slows brain aging," said study lead author Dr. Li Gan, the Burton P. and Judith B. Resnick Distinguished Professor in Neurodegenerative Diseases and director of the Helen and Robert Appel Alzheimer's Disease Research Institute at Weill Cornell Medicine.

Telomeres as an aging trigger

Aging is known to affect the brain in many ways. It shrinks key brain areas, makes neuronal communication less efficient, degrades the protective myelin-protein sheathing around nerve fibers, and renders the brain vulnerable to Alzheimer's, Parkinson's and other neurodegenerative diseases. The mechanisms by which these aging-related changes happen remain largely unknown, however.

In the new study, Gan and her colleagues sought some insights from a mouse model of aging that is based on molecules called telomeres. Often likened to the plastic caps that prevent shoelace ends from fraying, telomeres are protein-and-DNA constructions that protect the ends of chromosomes and keep them from sticking together. Telomeres in a cell generally shorten with each cell division and, below a certain length, can trigger senescence. The model used by Gan and her team has telomeres that shorten more quickly than normal, causing a syndrome that resembles accelerated aging.

The researchers observed that in these mice, though they were only in early middle age, their brains bore many of the usual signs of advanced aging, including reduced myelination of nerve fibers and reductions in neuronal function.

Credit: Neuron (2026). DOI:10.1016/j.neuron.2026.07.021

Microglia emerge as the key culprits

The team also noted particularly striking changes in appearance and gene activity in immune cells in the brain called microglia, which, unlike nondividing neurons, get progressively shorter telomeres as they continue to divide throughout life. Many of these microglia showed signs of being senescent.

The state of senescence has been studied mostly in cells outside the brain. Senescent cells, though they have stopped dividing, typically secrete proteins that promote inflammation and otherwise impair the function of nearby nonsenescent cells. The team found something similar with senescent microglia, whose mere presence impaired the functions of neurons as well as myelin-making oligodendrocytes. They identified DLK1 as the key secreted factor underlying this effect.

Evidence extends beyond one model

The researchers observed similar effects of DLK1 on both mouse and human-derived brain cells. They also showed that brain levels of DLK1 in normal mice are elevated with advanced aging and found evidence of a similar age-related rise in a large database of gene activity in human brain cells.

The results open up a promising area of investigation, Gan said. She noted that DLK1, apart from its potential as a therapeutic target, may be useful more broadly in making better animal models of brain aging.

Publication details

Bangyan Liu et al, Senescent microglia with shortened telomeres secrete soluble DLK1 to induce aging-associated hypomyelination and neuronal dysfunction, Neuron (2026). DOI: 10.1016/j.neuron.2026.07.021 www.cell.com/neuron/fulltext/S0896-6273(26)00577-5

Journal information: Neuron

Key medical concepts

Cellular SenescenceMicrogliaNeuronsOligodendroglia

Clinical categories

Neurology Provided by Weill Cornell Medical College Who's behind this story?

Lisa Lock

BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Protein secreted by immune cells may help drive brain aging (2026, August 11) retrieved 12 August 2026 from https://medicalxpress.com/news/2026-08-protein-secreted-immune-cells-brain.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.